Stock Price
3.43
Daily Change
0.10 2.90%
Monthly
-12.81%
Yearly
67.98%
Q2 Forecast
5.00

Acasti Pharma reported $20K in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Addus HomeCare USD 151.7M 17.64M Dec/2025
Amarin USD 126.83M 477K Dec/2025
Cassava Sciences USD 120K 697K Dec/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Option Care Health USD 473.57M 934K Dec/2025
Organigram Holdings CAD 49.94M 14.92M Dec/2025
Tilray USD 109.07M 2M Sep/2025